← All Foghorn Therapeutics INC filings

Foghorn Therapeutics INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
FHTX
Foghorn Therapeutics INC
DEF: Foghorn Therapeutics Sets 2026 Annual Meeting Date
Foghorn Therapeutics Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 24, 2026, to elect directors, ratify auditors, and vote on executive compensation.
NASDAQ
FHTX
Foghorn Therapeutics INC
DEFA14A: Foghorn Therapeutics Inc. Announces Annual Meeting of Stockholders
Foghorn Therapeutics Inc. will hold its annual meeting of stockholders on June 17, 2025, to elect directors and ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm.
NASDAQ
FHTX
Foghorn Therapeutics INC
DEF: Foghorn Therapeutics Sets Date for 2025 Annual Stockholders Meeting
Foghorn Therapeutics will hold its 2025 Annual Meeting of Stockholders virtually on June 17, 2025, to vote on the election of directors and ratification of the company's independent accounting firm.
NASDAQ
FHTX
Foghorn Therapeutics INC
DEFA14A: Foghorn Therapeutics Sets Date for Annual Stockholders Meeting
Foghorn Therapeutics will hold its annual stockholders meeting on June 26, 2024, to elect directors and ratify the selection of its independent auditor.
NASDAQ
FHTX
Foghorn Therapeutics INC
DEF 14A: Foghorn Therapeutics Sets Date for 2024 Annual Stockholders Meeting
Foghorn Therapeutics will hold its 2024 Annual Meeting of Stockholders virtually on June 26, 2024, to elect directors and ratify the selection of its independent accounting firm.